Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter J. Trainer
Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Related publications
Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening
Endocrine Abstracts
Combined Treatment for Acromegaly With Long-Acting Somatostatin Analogs and Pegvisomant: Long-Term Safety for Up to 4.5 Years (Median 2.2 Years) of Follow-Up in 86 Patients
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Preoperative Octreotide Therapy in Acromegaly: Associations Between Effects on Glucose Homeostasis and Biochemical Cure
Endocrine Abstracts
Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Long-Term Treatment of Acromegaly and Gigantism With Octreotide (SMS 201-995)
Folia Endocrinologica Japonica
Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
